1
Total Mentions
1
Documents
0
Connected Entities
HOUSE_OVERSIGHT_024003 - HOUSE_OVERSIGHT_024116
ustry to more normalized conditions due to the recent stronger IPO and M&A markets. Life Sciences Venture Fundraising Investments into Biopharma and Medical Devices Life Sciences Venture Fundraising - Dollars Raised ($B) ** Life Sciences Venture Financings — $ Invested ($B) and Count $10.0 $8.0 $6.0 $4.0 $2
Page: HOUSE_OVERSIGHT_024040 →No connected entities